title: [Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease].
abstract: OBJECTIVE
  Hypertension is one of the most prevalent and poorly controlled risk factors, especially in patients with established cardiovascular disease (CVD). The aim of this study was to describe the rate of blood pressure (BP) control and related risk factors.
  
  
  METHODS
  Multicenter, cross-sectional and observational registry of patients with hypertension recruited from cardiology and primary care outpatient clinics. Controlled BP defined as <140/90 mmHg.
  
  
  RESULTS
  55.4% of the 10 743 patients included had controlled BP and these had a slightly higher mean age. Patients with uncontrolled BP were more frequently male, with a higher prevalence of active smokers, obese patients, and patients with diabetes. The rate of controlled BP was similar in patients with or without CVD. Patients with uncontrolled BP had higher levels of blood glucose, total cholesterol, low density lipoproteins and uric acid. Patients with uncontrolled BP were receiving a slightly higher mean number of antihypertensive drugs compared to patients with controlled BP. Patients with CVD were more frequently receiving a renin-angiotensin-aldosterone axis inhibitor: 83.5% vs. 73.2% (P<.01). Multivariate analysis identified obesity and current smoking as independently associated with uncontrolled BP, both in patients with or without CVD, as well as relevant differences between the two groups on other factors.
  
  
  CONCLUSIONS
  Regardless of the presence of CVD, 55% of hypertensive patients had controlled BP. Lifestyle and diet, especially smoking and obesity, are independently associated with lack of BP control. Full English text available from: www.revespcardiol.org.
authors.affiliation: Departamento de Cardiología, Hospital Universitario de San Juan, 3550 Sant Joan d'Alacant, Alicante, Spain. acorderofort@gmail.com
authors.forename: Alberto
authors.initials: A
authors.lastname: Cordero
authors.forename: Vicente
authors.initials: V
authors.lastname: Bertomeu-Martínez
authors.forename: Pilar
authors.initials: P
authors.lastname: Mazón
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Fácila
authors.forename: Vicente
authors.initials: V
authors.lastname: Bertomeu-González
authors.forename: Juan
authors.initials: J
authors.lastname: Cosín
authors.forename: Enrique
authors.initials: E
authors.lastname: Galve
authors.forename: Julio
authors.initials: J
authors.lastname: Núñez
authors.forename: Iñaki
authors.initials: I
authors.lastname: Lekuona
authors.forename: José R
authors.initials: JR
authors.lastname: González-Juanatey
mesh_terms: D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology; D002318:Cardiovascular Diseases / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology; D048909:Diabetes Complications / Q000453:epidemiology; D050171:Dyslipidemias / Q000150:complications / Q000453:epidemiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000453:epidemiology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000453:epidemiology; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents